The Transformation of Clinical Trial Strategies in the Era of Decentralized and Hybrid Opportunities

The pandemic disrupted oncology clinical trials, as investigators were often pulled away to care for COVID patients and many patients were uncomfortable coming into hospitals due to the risks of getting COVID.